Thunbnail image
News   >  Infectious Disease   >  

Fingerprint Technology: The Future of Drug Screening

Published: 6/18/2024
      
Fingerprint drug screening
INBS
FDA 510(k)
Pharmacokinetic study
Drug testing
Opiates
Safety-critical industries
Non-invasive testing
Human sweat analysis
Rapid results

Key Takeaways

  • INBS is conducting a critical study for FDA approval of its fingerprint drug screening technology.
  • The technology uses fingerprint sweat for quick, non-invasive, and accurate drug testing.
  • Successful FDA approval could significantly impact workplace drug testing processes.

Did You Know?

Did you know that fingerprint sweat can be used to detect drug use within minutes?

Introduction to Fingerprint Drug Screening

Intelligent Bio Solutions Inc. (INBS), a leading medical technology firm, is revolutionizing the world of drug testing with its innovative fingerprint drug screening technology. This method offers a rapid, non-invasive approach to drug testing, making it a game-changer in various industries, especially those dealing with safety-critical tasks.

Advancements and FDA Approval

Recent developments have seen INBS moving into a critical phase of their journey towards getting FDA 510(k) clearance. This clearance is essential to confirm that their innovative screening method is both safe and effective. The ongoing Pharmacokinetic (PK) study is a vital step in this process, focusing on understanding how drugs are metabolized and excreted through human sweat.

The study aims to compare the results from fingerprint sweat samples with those from more traditional methods like blood, saliva, and urine samples, thereby ensuring the new method’s reliability and accuracy.

The Study and Its Objectives

INBS has kicked off its dosing and sampling phase for the PK study, with the expectations to wrap it up by the end of June 2024. This extensive study will gather data on the metabolism and distribution of commonly abused drugs, such as opiates, within the body. By the end of July 2024, the company plans to finalize the review of these results.

Peter Passaris, Vice President of Product Development at INBS, expressed his enthusiasm, highlighting the extensive efforts required to reach this stage. The success of this study is not just a milestone for INBS, but a significant step towards enhanced drug screening practices.

Benefits of Fingerprint Drug Screening

The fingerprint drug screening technology by INBS uses human sweat captured from fingerprints to detect drug usage. This method not only provides quick results within minutes but also ensures a hygienic, non-invasive, and easy-to-use process. This is particularly beneficial for employers in industries where safety is paramount, such as construction, manufacturing, and transportation.

The system is designed to test for substances like cocaine, methamphetamine, cannabis, and opiates, making it a comprehensive screening tool.

Potential Applications and Market Impact

Aside from workplace drug testing, this technology has the potential for broader applications, including in drug treatment centers, logistics firms, and even in coroners' offices. As the technology gains FDA approval and more widespread acceptance, its impact on the market could be substantial, simplifying and streamlining the drug testing process.

Moreover, the speed and ease of the test could improve efficiency and cost-effectiveness, providing a potent tool for maintaining workplace safety and compliance in various industries.

Conclusion

The advancements made by Intelligent Bio Solutions Inc. represent a significant leap forward in drug screening technology. As they progress through the FDA approval process, the potential for their fingerprint drug screening system to transform workplace safety and efficiency becomes increasingly apparent. The completion of their ongoing study will be a crucial indicator of their future success in this field.

References

  1. INBS official website
    http://www.ibs.inc/
  2. FDA 510(k) submission process
    https://www.fda.gov/medical-devices/premarket-notification-510k
  3. Pharmacokinetics Explained
    https://emedicine.medscape.com/article/2172240-overview